China’s first domestic mpox vaccine approved for clinical trials
BEIJING: China delivered its first domestically developed mpox vaccine into clinical trials on Monday, Global Times reported.
The vaccine, independently developed by the Shanghai Institute of Biological Products, a subsidy of the China National Pharm…